Outcomes of COVID-19 amongst patients with ongoing use of inhaled corticosteroids – a systematic review & meta-analysisReviews Published on 2023-12-012024-09-05 Journal: Le Infezioni in Medicina [Category] update2024, [키워드] COVID-19 outcomes inhaled corticosteroids mortality risk respiratory pathologies systematic review and meta-analysis [DOI] 10.53854/liim-3104-3 PMC 바로가기 [Article Type] Reviews
Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary diseaseArticle Published on 2022-07-012023-07-08 Journal: Infectious diseases (London, England) [Category] COVID19(2023년), [키워드] COPD Coronavirus infection COVID-19 disease severity inhaled corticosteroids Mortality [DOI] 10.1080/23744235.2022.2050422
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)Randomized Controlled Trial Published on 2022-07-012022-10-04 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 신약개발, 임상, 치료법, [키워드] absence Adults adverse events adverse outcome alleviation of symptoms Analysis ARMS Blood Ciclesonide clinical Comorbidity control arm COVID-19 COVID-19 outpatient criteria Day death died Efficacy Endpoint European Medicines Agency Evidence Evolution Follow-up Hospitalization Hospitalized improvement Inhaled inhaled corticosteroid inhaled corticosteroids intent-to-treat interim analysis interquartile range involved median age median time men Open-label Other outcome Outpatient outpatients Oxygen therapy parameter participant patients with COVID-19 primary efficacy endpoint primary endpoint randomised controlled trial Randomized controlled trial Randomly reached reducing reported risk risk factor RT-PCR Safety Monitoring Board scale secondary sustained Symptom the WHO Treatment Trial women worsening [DOI] 10.1016/j.cmi.2022.02.031 PMC 바로가기 [Article Type] Randomized Controlled Trial
Severe asthma and COVID-19: lessons from the first waveReview Published on 2022-02-012023-07-06 Journal: The Journal of asthma : official journal of the Association for the Care of [Category] COVID19(2023년), SARS, [키워드] Asthma biologic agents COVID-19 inhaled corticosteroids Oral corticosteroids SARS-CoV-2 Severe asthma [DOI] 10.1080/02770903.2020.1861622 [Article Type] Review
The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort StudyMulticenter Study Published on 2022-02-012023-07-07 Journal: Journal of Intensive Care Medicine [Category] COVID19(2023년), [키워드] 30-Day mortality COVID-19 Critically ill inhaled corticosteroids intensive care units SARS-CoV-2 [DOI] 10.1177/08850666211053548 [Article Type] Multicenter Study
Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated PatientsArticle Published on 2022-01-132023-06-15 Journal: The journal of allergy and clinical immunology. In [Category] MERS, SARS, [키워드] ACE2, angiotensin converting enzyme 2 AEC, Absolute eosinophil count Asthma BMI, Body mass index CBC, complete blood count CCCRR, Cleveland Clinic COVID-19 Research Registry chronic obstructive pulmonary disease COPD, Chronic obstructive pulmonary disease COVID-19 COVID-19, Coronavirus disease 2019 eosinophilia iCS, Inhaled corticosteroids ICU, Intensive care unit inhaled corticosteroids RCT, Randomized controlled trial SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 T2, Type 2 [DOI] 10.1016/j.jaip.2021.12.034 PMC 바로가기
The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patientsObservational Study Published on 2022-01-012022-10-05 Journal: Journal of infection and public health [Category] SARS, 임상, [키워드] Affect Alter Asthma asthmatic patient Asthmatic patients being Cancer city Clinical course Clinical outcome clinical outcomes clinical variable Combination complications conducted COVID-19 COVID-19 severity determine diabete disease severity Effect Evidence hypertensive ICS ICS therapy ICU admission Infection Inhaled inhaled corticosteroid inhaled corticosteroids King Logistic regression material medication history Mortality Occurrence pandemic Patient Prevent retrospective Retrospective study risk severe disease severity of COVID-19 significant difference significantly increased therapeutic option Ventilation viral infection was used were excluded [DOI] 10.1016/j.jiph.2021.12.003 PMC 바로가기 [Article Type] Observational Study
Association between inhaled corticosteroid use and COVID ‐19 outcomesOriginal Article Published on 2021-08-242023-06-16 Journal: Pharmacoepidemiology and drug safety [Category] MERS, SARS, [키워드] cohort study COVID‐19 inhaled corticosteroids pharmacoepidemiology [DOI] 10.1002/pds.5345 PMC 바로가기 [Article Type] Original Article
Systemic corticosteroids for the treatment of COVID-19COVID-19 치료를 위한 전신 코르티코스테로이드Review Published on 2021-08-162022-09-11 Journal: The Cochrane database of systematic reviews [Category] SARS, 임상, [키워드] 95% CI 95% confidence interval acute respiratory syndrome adjust adverse event adverse events age all-cause mortality analysed Analysis applicability approach arising Arm Asymptomatic asymptomatic infection baseline benefit caution CENTRAL certainty certainty of evidence change citation Cochrane COVID-19 Study Register Combination comparison Comparisons composite endpoint control group coronavirus disease coronavirus diseases Corticosteroid Corticosteroids COVID-19 Data collection death Descriptive statistics Dexamethasone Diagnosis direction disease disease severity dosage dosages dose doses doses of corticosteroids effective Effects eligible endpoints estimate Ethnicity evaluated Evidence excluded Factor FIVE Follow-up Gender heterogeneous high risk hospital-acquired infections hospitalised hyper-inflammation identify include index individual Inhaled inhaled corticosteroids inherent invasive Invasive mechanical ventilation invasive ventilation life limitation long-COVID majority median medRxiv methodology Methylprednisolone Middle East Middle East respiratory syndrome Mild Mild disease Mortality MOST New nine non-hospitalised occurred Other outcomes outcome outcomes Outpatient outpatients participant Participants Patient people with COVID-19 Placebo Population Quality Quality of life randomisation randomised randomised controlled trial Randomised controlled trials RCT RCTs reduce reduction in regimen reported Respiratory Support risk risk difference risk of bia risk ratio Safe Science Citation Index searched Selection Serious Adverse Events Severe acute respiratory syndrome standard care subgroup subgroups subsequent suspected diagnosis symptomatic symptomatic COVID-19 syndrome systematic review systemic systemic corticosteroid systemic corticosteroids the WHO therapy topical treat Treatment Trial Ventilation ventilator-free day Ventilator-free days Web of Science WHO ICTRP [DOI] 10.1002/14651858.CD014963 PMC 바로가기 [Article Type] Review
Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019동물원성 코로나바이러스 전염병: 중증 급성 호흡기 증후군, 중동 호흡기 증후군 및 코로나바이러스 질병 2019Review Published on 2021-04-012022-09-11 Journal: Annals of allergy, asthma & immunology : official [Category] SARS, 치료제, [키워드] acute respiratory syndrome Affect allergy Antiviral Asthma atopy Basic science biologic Biologic therapy caused Clinical characteristics clinical courses clinical manifestation clinical manifestations Clinical outcome coronavirus coronavirus disease Coronavirus disease 2019 coronavirus epidemics Corticosteroids courses COVID-19 COVID-19 infection database deaths deficiencies deficiency disease disease control Effect effective Efficacy Epidemiology fatal disease immunodeficiency immunology immunomodulator immunomodulators Inconclusive Infection inhaled corticosteroid inhaled corticosteroids international public health landscape less maintain MERS Middle East Middle East respiratory syndrome Mild National nucleic acid nucleic acid amplification nucleic acid amplification tests organ organ system outcomes Patient primary antibody Primary Immunodeficiency Severe acute respiratory syndrome syndrome T-cell Therapies therapy Treatment treatment for COVID-19 Virology worldwide pandemic Zoonotic coronavirus [DOI] 10.1016/j.anai.2020.11.021 PMC 바로가기 [Article Type] Review